Skip to content

Treatment of Sciatica pain with homoeopathy

A comparative study of centesimal potency & fifty millesimal potency in the treatment of sciatica pain in adults-an open label parallel arm pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054046
Enrollment
60
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Individualised homoeopathic medicines in fifty millesimal potencies: Intervention is planned as administering indicated homoeopathic medicine in fifty millesimal potencies, as decided a
dosage and repetition depending upon the requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP) certified firm. All patients will be given general advices on

Sponsors

Mahesh Bhattacharya Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients experiencing low back pain radiating to lower limbs (unilateral or bilateral) since 3 months or more ( 2018/19 ICD-20-CM diagnosis code M54.31); confirmed by straight leg raising test (SLR) test. 2.Both sexes. 3.Literate patients, must be able to read and write bengali and or English. 4.Patients providing written informed consent or a thumb print on the already written informed consent form

Exclusion criteria

Exclusion criteria: 1.Patients suffering from uncontrolled diabetes mellitus, cardiovascular diseases, Thyroid disorders. 2.Patient having a history of surgery to the lower pain. 3.Patients who are already diagnosed with disc prolapse, psoriatic arthritis and gout, cases willing for or requiring immediate surgical intervention or already underwent any major spinal or hip surgery in last 6 months. 4.Patients who are undergoing treatment with NSAIDs during 6 weeks prior enrollment in the study. 5.Spinal corticosteroid injection within 6 months. 6.Diagnosed cases of unstable Psychiatric illness. 7.Pregnant and non-lactating women. 8.Self-reported immune-compromised state. 9.Undergoing any homoeopathic treatment within last 2 weeks. Substance abuse and/or dependence.

Design outcomes

Primary

MeasureTime frame
Roland Morris Disability Questionnaire (RMDQ)Timepoint: At baseline, every month, upto 3 months.

Secondary

MeasureTime frame
Visual analog scale (VAS)Timepoint: At baseline, every month, upto 3 months.

Countries

India

Contacts

Public ContactDr Baishakhi Ghosh

West Bengal University of Health Sciences

madhusreedutta2811@gmail.com08777486871

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026